AMN Healthcare AMN Non-current Restricted Cash and Cash Equivalents
Non-current Restricted Cash and Cash Equivalents at other companies
Other financials
Where this comes from
Reported directly by AMN Healthcare in its filing.
Tagged under the XBRL concept us-gaap:RestrictedCashAndInvestmentsNoncurrent.
The official record: AMN Healthcare’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about AMN Healthcare's non-current restricted cash and cash equivalents.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AMN Healthcare's non-current restricted cash and cash equivalents?
- AMN Healthcare (AMN) reported non-current restricted cash and cash equivalents of $45.81M in Q1 2026.
- How has AMN Healthcare's non-current restricted cash and cash equivalents changed year-over-year?
- AMN Healthcare's non-current restricted cash and cash equivalents increased by 1.7% year-over-year, from $45.07M to $45.81M.
- What is the long-term trend for AMN Healthcare's non-current restricted cash and cash equivalents?
- Over 5 years (2020 to 2025), AMN Healthcare's non-current restricted cash and cash equivalents has grown at a -5.8% compound annual growth rate (CAGR), from $61.35M to $45.61M.
- What does non-current restricted cash and cash equivalents mean?
- This refers to cash and cash equivalents held in escrow or designated for specific long-term obligations that are not accessible for general corporate operations. These funds are typically tied to collateral requirements, long-term debt covenants, or specific regulatory mandates. A significant balance indicates capital that is effectively locked away from working capital needs for a period exceeding one year.